From: Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer
Clinico-pathological parameters | Number of patients | % |
---|---|---|
Total | 109 | 100 |
Age (mean; ± SD) | 63 ± 11.9 | |
male | 70 | 64.2 |
female | 39 | 35.8 |
Side | ||
left | 49 | 45 |
right | 60 | 55 |
Surgery | ||
PN | 27 | 24.8 |
RN | 82 | 75.2 |
Histology | ||
clear cell | 78 | 71.6 |
papillary | 22 | 20.2 |
chromophobe | 2 | 1.8 |
other/not classified | 7 | 6.4 |
Stage | ||
pT1a | 34 | 31.2 |
pT1b | 30 | 27.5 |
pT2 | 5 | 4.6 |
pT3a | 13 | 11.9 |
pT3b/c | 27 | 24.8 |
pT4 | 0 | 0 |
LN metastasis 1 | 11 | 10.1 |
Pulmonal/visceral metastasis 1 | 23 | 21.1 |
Advanced/metastatic disease (pT3-4 and/or N/M+) | 48 | 44.0 |
Grade | ||
G1 | 18 | 16.5 |
G1-2 | 15 | 13.8 |
G2 | 58 | 53.2 |
G2-3 | 7 | 6.4 |
G3 | 11 | 10.1 |